Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
AstraZeneca Buys Up Asian Subsidiaries
by Jean-François Tremblay
March 10, 2014
| A version of this story appeared in
Volume 92, Issue 10
AstraZeneca is assuming full ownership of its subsidiaries in India and Japan. In India, AstraZeneca is moving to acquire the 25% of AstraZeneca Pharma India, which is listed on the Bombay Stock Exchange, that it doesn’t already own. The Indian unit reported sales of $63 million in its latest fiscal year. In Japan, AstraZeneca will acquire the 20% stake in its Japanese subsidiary now owned by Sumitomo Chemical.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter